1. WalkerCM, MoodyDJ, StitesDP, LevyJA (1986) CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1563–1566.
2. SchmitzJE, KurodaMJ, SantraS, SassevilleVG, SimonMA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857–860.
3. LoffredoJT, BeanAT, BealDR, LeonEJ, MayGE, et al. (2008) Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J Virol 82: 1723–1738.
4. YuXG, AddoMM, RosenbergES, RodriguezWR, LeePK, et al. (2002) Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol 76: 8690–8701.
5. YewdellJW, BenninkJR (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17: 51–88.
6. AkramA, InmanRD (2012) Immunodominance: a pivotal principle in host response to viral infections. Clin Immunol 143: 99–115.
7. ChenW, McCluskeyJ (2006) Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines. Adv Cancer Res 95: 203–247.
8. CaoW, Myers-PowellBA, BracialeTJ (1996) The weak CD8+ CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J Immunol 157: 505–511.
9. HaeryfarSM, HickmanHD, IrvineKR, TscharkeDC, BenninkJR, et al. (2008) Terminal deoxynucleotidyl transferase establishes and broadens antiviral CD8+ T cell immunodominance hierarchies. J Immunol 181: 649–659.
10. MessaoudiI, Guevara PatinoJA, DyallR, LeMaoultJ, Nikolich-ZugichJ (2002) Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298: 1797–1800.
11. BelzGT, StevensonPG, DohertyPC (2000) Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol 165: 2404–2409.
12. DengY, YewdellJW, EisenlohrLC, BenninkJR (1997) MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 158: 1507–1515.
13. HarariA, DutoitV, CelleraiC, BartPA, Du PasquierRA, et al. (2006) Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211: 236–254.
14. BettsMR, NasonMC, WestSM, De RosaSC, MiguelesSA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781–4789.
15. AlmeidaJR, PriceDA, PapagnoL, ArkoubZA, SauceD, et al. (2007) Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 204: 2473–2485.
16. CritchfieldJW, LemongelloD, WalkerDH, GarciaJC, AsmuthDM, et al. (2007) Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol 81: 5460–5471.
17. FerreAL, HuntPW, CritchfieldJW, YoungDH, MorrisMM, et al. (2009) Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 113: 3978–3989.
18. PerreauM, LevyY, PantaleoG (2013) Immune response to HIV. Curr Opin HIV AIDS 8: 333–340.
19. RodriguezF, SlifkaMK, HarkinsS, WhittonJL (2001) Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities. J Virol 75: 7399–7409.
20. BaronC, MeunierMC, CaronE, CoteC, CameronMJ, et al. (2006) Asynchronous differentiation of CD8 T cells that recognize dominant and cryptic antigens. J Immunol 177: 8466–8475.
21. PayneRP, KloverprisH, SachaJB, BrummeZ, BrummeC, et al. (2010) Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol 84: 10543–10557.
22. AllenTM, MotheBR, SidneyJ, JingP, DzurisJL, et al. (2001) CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing. J Virol 75: 738–749.
23. NewbergMH, McEversKJ, GorgoneDA, LiftonMA, BaumeisterSH, et al. (2006) Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 176: 319–328.
24. SethA, OurmanovI, SchmitzJE, KurodaMJ, LiftonMA, et al. (2000) Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge. J Virol 74: 2502–2509.
25. PriceDA, AsherTE, WilsonNA, NasonMC, BrenchleyJM, et al. (2009) Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J Exp Med 206: 923–936.
26. YamamotoT, JohnsonMJ, PriceDA, WolinskyDI, AlmeidaJR, et al. (2012) Virus inhibition activity of effector memory CD8(+) T cells determines simian immunodeficiency virus load in vaccinated monkeys after vaccine breakthrough infection. J Virol 86: 5877–5884.
27. Wrzesien-KusA, SmolewskiP, Sobczak-PlutaA, WierzbowskaA, RobakT (2004) The inhibitor of apoptosis protein family and its antagonists in acute leukemias. Apoptosis 9: 705–715.
28. KumarS (2009) Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more? Nat Rev Cancer 9: 897–903.
29. NguyenHG, ChinnappanD, UranoT, RavidK (2005) Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol Cell Biol 25: 4977–4992.
30. StewartS, FangG (2005) Destruction box-dependent degradation of aurora B is mediated by the anaphase-promoting complex/cyclosome and Cdh1. Cancer Res 65: 8730–8735.
31. SatyanarayanaA, KaldisP (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28: 2925–2939.
32. OlsonMF, AshworthA, HallA (1995) An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270–1272.
33. IyerJ, MogheS, FurukawaM, TsaiMY (2011) What's Nu(SAP) in mitosis and cancer? Cell Signal 23: 991–998.
34. FangZ, XingF, BronnerC, TengZ, GuoZ (2009) ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells. Cell Immunol 257: 80–87.
35. TienAL, SenbanerjeeS, KulkarniA, MudbharyR, GoudreauB, et al. (2011) UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochem J 435: 175–185.
36. KastanMB, ZhanQ, el-DeiryWS, CarrierF, JacksT, et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587–597.
37. LetvinNL, RaoSS, MontefioriDC, SeamanMS, SunY, et al. (2011) Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci Transl Med 3: 81ra36.
38. PitcherCJ, HagenSI, WalkerJM, LumR, MitchellBL, et al. (2002) Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168: 29–43.
39. TakataH, TakiguchiM (2006) Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 177: 4330–4340.
40. TomiyamaH, MatsudaT, TakiguchiM (2002) Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J Immunol 168: 5538–5550.
41. ChampagneP, OggGS, KingAS, KnabenhansC, EllefsenK, et al. (2001) Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106–111.
42. SlifkaMK, RodriguezF, WhittonJL (1999) Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 401: 76–79.
43. ValituttiS, MullerS, DessingM, LanzavecchiaA (1996) Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 183: 1917–1921.
44. KershGJ, KershEN, FremontDH, AllenPM (1998) High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9: 817–826.
45. HollerPD, KranzDM (2003) Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255–264.
46. MatsuiK, BonifaceJJ, SteffnerP, ReayPA, DavisMM (1994) Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A 91: 12862–12866.
47. TianS, MaileR, CollinsEJ, FrelingerJA (2007) CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J Immunol 179: 2952–2960.
48. LyonsDS, LiebermanSA, HamplJ, BonifaceJJ, ChienY, et al. (1996) A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5: 53–61.
49. UenoT, TomiyamaH, FujiwaraM, OkaS, TakiguchiM (2004) Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions. J Immunol 173: 5451–5457.
50. CaleEM, BazickHS, RianprakaisangTA, AlamSM, LetvinNL (2011) Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding. J Immunol 187: 3300–3313.
51. TriebelF, JitsukawaS, BaixerasE, Roman-RomanS, GeneveeC, et al. (1990) LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 171: 1393–1405.
52. LinsleyPS, GreeneJL, TanP, BradshawJ, LedbetterJA, et al. (1992) Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 176: 1595–1604.
53. WherryEJ, HaSJ, KaechSM, HainingWN, SarkarS, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670–684.
54. TakamuraS, Tsuji-KawaharaS, YagitaH, AkibaH, SakamotoM, et al. (2010) Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors. J Immunol 184: 4696–4707.
55. PriceP, KeaneN, GrayL, LeeS, GorryPR, et al. (2006) CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy. Viral Immunol 19: 734–740.
56. BlackburnSD, ShinH, HainingWN, ZouT, WorkmanCJ, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29–37.
57. LimAY, PriceP, BeilharzMW, FrenchMA (2006) Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV-infected patients responding to antiretroviral therapy. Immunol Cell Biol 84: 530–536.
58. PenaJ, JonesNG, BousheriS, BangsbergDR, CaoH (2013) Lymphocyte Activation Gene-3 Expression Defines a Discrete Subset of HIV-Specific CD8 T Cells That Is Associated with Lower Viral Load. AIDS Res Hum Retroviruses [epub ahead of print].
59. YeeC, SavagePA, LeePP, DavisMM, GreenbergPD (1999) Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol 162: 2227–2234.
60. IglesiasMC, AlmeidaJR, FastenackelsS, van BockelDJ, HashimotoM, et al. (2011) Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood 118: 2138–2149.
61. BennettMS, JosephA, NgHL, GoldsteinH, YangOO (2010) Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes. AIDS 24: 2619–2628.
62. HarariA, CelleraiC, EndersFB, KostlerJ, CodarriL, et al. (2007) Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci U S A 104: 16233–16238.
63. ViganoS, EndersFB, MiconnetI, CelleraiC, SavoyeAL, et al. (2013) Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells. PLoS Pathog 9: e1003423.
64. ConradJA, RamalingamRK, SmithRM, BarnettL, LoreySL, et al. (2011) Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity. J Immunol 186: 6871–6885.
65. LeslieAJ, PfafferottKJ, ChettyP, DraenertR, AddoMM, et al. (2004) HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 10: 282–289.
66. O'ConnorDH, AllenTM, VogelTU, JingP, DeSouzaIP, et al. (2002) Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 8: 493–499.
67. VogelTU, FriedrichTC, O'ConnorDH, RehrauerW, DoddsEJ, et al. (2002) Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? J Virol 76: 11623–11636.
68. MolldremJJ, LeePP, KantS, WiederE, JiangW, et al. (2003) Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J Clin Invest 111: 639–647.
69. Van ParijsL, AbbasAK (1998) Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280: 243–248.
70. BarouchDH, KunstmanJ, GlowczwskieJ, KunstmanKJ, EganMA, et al. (2003) Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J Virol 77: 7367–7375.
71. BarouchDH, KunstmanJ, KurodaMJ, SchmitzJE, SantraS, et al. (2002) Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415: 335–339.
72. BergerCT, FrahmN, PriceDA, MotheB, GhebremichaelM, et al. (2011) High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control. J Virol 85: 9334–9345.
73. MotheB, LlanoA, IbarrondoJ, ZamarrenoJ, SchiauliniM, et al. (2012) CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One 7: e29717.
74. TurnbullEL, LopesAR, JonesNA, CornforthD, NewtonP, et al. (2006) HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol 176: 6130–6146.
75. St LegerAJ, PetersB, SidneyJ, SetteA, HendricksRL (2011) Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice. J Immunol 186: 3927–3933.
76. La GrutaNL, DohertyPC, TurnerSJ (2006) A correlation between function and selected measures of T cell avidity in influenza virus-specific CD8+ T cell responses. Eur J Immunol 36: 2951–2959.
77. FahmyTM, BielerJG, EdidinM, SchneckJP (2001) Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity 14: 135–143.
78. XiaoZ, MescherMF, JamesonSC (2007) Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. J Exp Med 204: 2667–2677.
79. WangXL, AltmanJD (2003) Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays. J Immunol Methods 280: 25–35.
80. BonifaceJJ, ReichZ, LyonsDS, DavisMM (1999) Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc Natl Acad Sci U S A 96: 11446–11451.
81. WillcoxBE, GaoGF, WyerJR, LadburyJE, BellJI, et al. (1999) TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10: 357–365.
82. GarciaKC, RaduCG, HoJ, OberRJ, WardES (2001) Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 98: 6818–6823.
83. Varela-RohenaA, MolloyPE, DunnSM, LiY, SuhoskiMM, et al. (2008) Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med 14: 1390–1395.
84. KnappLA, LehmannE, PiekarczykMS, UrvaterJA, WatkinsDI (1997) A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. Tissue Antigens 50: 657–661.
85. AltmanJD, MossPA, GoulderPJ, BarouchDH, McHeyzer-WilliamsMG, et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94–96.
86. KurodaMJ, SchmitzJE, BarouchDH, CraiuA, AllenTM, et al. (1998) Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Exp Med 187: 1373–1381.
87. MakedonasG, BanerjeePP, PandeyR, HerspergerAR, SanbornKB, et al. (2009) Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity. J Immunol 182: 5560–5569.
88. AlamSM, DaviesGM, LinCM, ZalT, NasholdsW, et al. (1999) Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10: 227–237.
89. AlamSM, TraversPJ, WungJL, NasholdsW, RedpathS, et al. (1996) T-cell-receptor affinity and thymocyte positive selection. Nature 381: 616–620.